Darrin Mangiacarne will be Spero’s central Indiana medical director. He will oversee the launch and growth of clinics in the area. / Photo courtesy of Spero
By MATT BLOIS
The Brentwood addiction treatment company Spero has expanded to Indianapolis, and has hired a medical director for the central part of the state.
Spero formed in in 2018, acquiring a group of clinics in Kentucky, Ohio and Indiana from another healthcare company called SelfRefind. Their clinics now serve more than 5,300 patients a month.
In an interview with the Brentwood Home Page, CEO Steve Priest said he felt a moral obligation to expand quickly. The company already has two locations in southern Indiana. The new clinic will be the first in the capital city. It is scheduled to open on March 1.
Spero also hired Darrin Mangiacarne to be the medical director for central Indiana. Mangiacarne was the co-chair of the Indiana Attorney General’s prescription drug task force and is the current president of the Indiana chapter of the American Society of Addiction Medicine.
I am looking forward to joining this dynamic mission-oriented healthcare organization https://t.co/YnajbDBkKH
— Spero Health (@SperoHealth1) January 29, 2019
Mangiacarne will oversee the launch and growth of clinics in the central Indiana area.
According to researchers at Indiana University, overdose deaths in the state have quadrupled since 1999 and overdoses cost the state more than $1 billion a year.
Investors such as Heritage Group, Health Velocity Capita, Frist Cressey Ventures and South Central Inc. have given Spero financial backing.
Former Senator Bill Frist, along with executives from South Central, Health Velocity Capital and Heritage Group are on the company’s board of directors.